Brussels, Belgium | Xinhua | The European Commission on Monday granted conditional marketing authorization for Nuvaxovid, the fifth COVID-19 vaccine authorized in the European Union (EU). The authorization of the vaccine, developed by Novavax, followed a scientific recommendation based on an assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency …
The post European Commission authorizes fifth vaccine against COVID-19 appeared first on The Independent Uganda:.
